Complicated Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Complicated Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
Phase 3 trial update for cefepime-tazobactam in complicated urinary tract infection and acute pyelonephritis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40) [Phase 3]
Phase 3 clinical trial evaluating intravenous imipenem/cilastatin/XNW4107 vs meropenem in hospitalized adults with complicated urinary tract…
-
FDA approval · 2023-02-10FDA Approved: ZEMDRI (PLAZOMICIN) — Supplemental Application (Cipla Therapeutics Inc.)
FDA approved a supplemental application for ZemdrI (plazomicin) from Cipla Therapeutics Inc.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
Phase 3 trial comparing oral tebipenem pivoxil hydrobromide (SPR994) to IV ertapenem in complicated urinary tract infection and acute pyelon…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034) [Phase 2]
Phase 2 trial comparing MK-7625A to meropenem in pediatric patients with complicated urinary tract infection; study completed with posted re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections [Phase 2]
Phase 2 trial update for meropenem-FL058 in complicated urinary tract infection and acute pyelonephritis.
-
FDA approval · 2021-02-16FDA Approved: PIPERACILLIN, TAZOBACTAM — Original Application (Sagent Pharmaceuticals)
FDA approves Sagent Pharmaceuticals' generic Piperacillin-tazobactam for intravenous use under Original Application, enabling a generic vers…
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults [Phase 3]
Phase 3 trial comparing sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin for complicated uri…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens [Phase 3]
Phase 3 trial evaluating Cefiderocol (S-649266) versus best available therapy for severe infections due to carbapenem-resistant Gram-negativ…
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating intravenous benapenem for efficacy and safety in patients with complicated urinary tract infecti…
-
FDA approval · 2020-07-15FDA Approved: ZEMDRI (PLAZOMICIN) — Supplemental Application (Cipla Therapeutics Inc.)
FDA approved a supplemental application for ZemdrI (plazomicin) submitted by Cipla Therapeutics Inc.
-
FDA approval · 2020-05-25FDA Approved: VABOMERE — Supplemental Application (Melinta Therapeutics, LLC)
The FDA approved a supplemental application for VABOMERE (meropenem-vaborbactam) from Melinta Therapeutics to modify/expand its labeling.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections [Phase 2]
Phase 2 trial comparing intravenous cefiderocol to imipenem/cilastatin for complicated urinary tract infections has completed with results p…
-
FDA approval · 2019-11-14FDA Approved: FETROJA — Original Application (Shionogi Inc.)
The FDA approves Fetroja (cefiderocol sulfate tosylate) from Shionogi in an Original New Drug Application for the treatment of complicated u…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections [Phase 3]
Phase 3 trial comparing eravacycline to ertapenem for complicated urinary tract infections has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017) [Phase 3]
Phase 3 trial evaluating efficacy and safety of imipenem/cilastatin/relebactam (MK-7655A) in Japanese participants with complicated intra-ab…
-
FDA approval · 2019-07-16FDA Approved: RECARBRIO — Original Application (Merck Sharp & Dohme LLC)
FDA approved RECARBRIO (imipenem/cilastatin/relebactam) under NDA 212819 from Merck Sharp & Dohme LLC, marking the original approval of this…
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections [Phase 2]
Phase 2 clinical trial evaluating intravenous sulbactam-ETX2514 for hospitalized adults with complicated urinary tract infection and acute p…
-
FDA approval · 2019-06-03FDA Approved: ZERBAXA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for ZERBAXA (ceftolozane and tazobactam) from Merck, resulting in changes to the product labeling.
-
FDA approval · 2019-03-14FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for AVYCAZ (ceftazidime-avibactam) that updates labeling in connection with the supplement.
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections [Phase 2, Phase 3]
Clinical trial update comparing IV fosfomycin (ZTI-01) to piperacillin/tazobactam for complicated urinary tract infections and acute pyelone…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections [Phase 3]
A Phase 3 clinical trial comparing eravacycline to levofloxacin for complicated urinary tract infections has completed with posted results i…
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) [Phase 3]
Phase 3 trial update of ceftolozane/tazobactam in Japanese participants with uncomplicated pyelonephritis and complicated urinary tract infe…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP) [Phase 3]
Phase 3 trial comparing plazomicin to meropenem for complicated urinary tract infection with acute pyelonephritis has completed with results…
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) [Phase 2]
Phase 2 trial comparing plazomicin to levofloxacin for complicated urinary tract infection and acute pyelonephritis has completed with resul…